> ## Content Index
> Fetch the complete content index at: https://www.healthdatacon.io/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guidance Issued on New Medicaid Health Home Program under Reform Law
- URL: https://www.healthdatacon.io/articles/guidance-issued-on-new-medicaid--c2-91health-home-c2-92-program-under-reform-law/
- Published: 2013-01-15T17:13:42.000Z
- Updated: 2013-01-15T17:13:42.000Z
- Description: The Centers for Medicare and Medicaid Services has released to state Medicaid programs guidance on new Health Home core quality measures under section 2703 of the Affordable Care Act.
- Author: Joseph Goedert
- Tags: Policy

The Centers for Medicare and Medicaid Services has released to state Medicaid programs guidance on new “Health Home” core quality measures under section 2703 of the Affordable Care Act.  
  
The section authorizes health homes, a person-centered care delivery model focusing on improving outcomes for Medicaid beneficiaries with chronic conditions. The guidance comes in the form of a “recommended” core set of quality measures to assess the new care delivery model, but CMS intends to implement these measures in forthcoming rules.  
  
The measures are not mandated until the rules are promulgated, but the guidance will aid states as they consider design and implementation of their health home programs, according to a [letter to state Medicaid directors](http://www.medicaid.gov/Federal-Policy-Guidance/downloads/SMD-13-001.pdf?ref=healthdatacon.io). “This advance notice will also give states time to share information with their health care providers, which is important, since health home providers will be required to report health quality measures in order to receive payment.”  
  
The measures cover adult body mass index assessment, ambulatory care-sensitive condition admission, care transition records transmitted to health care professionals, follow-up after hospitalization for mental illness, an all-cause readmission plan, screening for clinical depression and a follow-up plan, alcohol and other drug dependency treatment, and controlling high blood pressure.